{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:11:21Z","timestamp":1725444681333},"reference-count":9,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:p>Fibromyalgia is a form of non-articular rheumatism in which inflammatory cytokines seem to be involved. However, there is still no analytical specific diagnostic criterion for this disease. The aim was to examine a possible role of fractalkine as a biomarker in fibromyalgia. Plasma levels of soluble fractalkine were compared between women diagnosed with fibromyalgia (n=17) and healthy women (n=10) as controls. Fractalkine released by monocytes was also evaluated. Fibromyalgia patients showed lower plasma fractalkine than healthy women. Since most inflammatory pathologies show elevated plasma levels of soluble fractalkine, the results may contribute towards a differential diagnosis for fibromyalgia.<\/jats:p>","DOI":"10.1590\/0001-3765201420130081","type":"journal-article","created":{"date-parts":[[2014,12,7]],"date-time":"2014-12-07T19:33:23Z","timestamp":1417980803000},"page":"1915-1917","source":"Crossref","is-referenced-by-count":3,"title":["Soluble fractalkine in the plasma of fibromyalgia patients"],"prefix":"10.1590","volume":"86","author":[{"given":"JUAN J.","family":"GARCIA","sequence":"first","affiliation":[{"name":"University of Extremadura, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EDUARDO","family":"ORTEGA","sequence":"additional","affiliation":[{"name":"University of Extremadura, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000341664","article-title":"Inflammatory\/stress feedback dysregulation in women with fibromyalgia","volume":"19","author":"Bote ME","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"37993","DOI":"10.1074\/jbc.M106434200","article-title":"Tumor necrosis factor-alpha-converting enzyme(ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)","volume":"276","author":"Garton K","year":"2001","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutivecleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-celladhesion","volume":"102","author":"Hundhausen C","year":"2003","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2011.00082","article-title":"Pathological role of fractalkine\/CX3CL1 in rheumatic diseases: a unique chemokine with multiple functions","volume":"2","author":"Jones B","year":"2012","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2008.04.011","article-title":"Glia in pathological pain: A role for fractalkine","volume":"198","author":"Milligan E","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-007-0403-9","article-title":"The classification of fibromyalgia syndrome","volume":"27","author":"M\u00fcller W","year":"2007","journal-title":"Rheumatol Int"},{"key":"ref7","first-page":"42","article-title":"Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances","volume":"15","author":"Ortega E","year":"2009","journal-title":"Exerc Immunol Rev"},{"key":"ref8","first-page":"521","article-title":"Neuroendocrineand immune aspects of fibromyalgia","volume":"15","author":"Van West D","year":"2001","journal-title":"Bio Drugs"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe F","year":"2010","journal-title":"Arthritis Care Res"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v86n4\/0001-3765-aabc-0001-3765201420130081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T00:31:52Z","timestamp":1650760312000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652014000401915&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0001-37652014000401915"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765201420130081","relation":{},"ISSN":["0001-3765"],"issn-type":[{"value":"0001-3765","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}